Having served patients for over three decades, Northwest Face & Body provides surgical and non-surgical cosmetic treatments
Tirzepatides average weight loss of 2022% in clinical trials rivals the results of some surgical procedures with significantly less risk, no recovery time, and the ability to stop treatment if needed
GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease
Lower intake, combined with individual dietary patterns and preexisting deficiencies, may increase the risk of insufficient intake of nutrients such as vitamin D, B vitamins, and other micronutrients